157 related articles for article (PubMed ID: 25750036)
1. Mutation-introduced dimerization of receptor tyrosine kinases: from protein structure aberrations to carcinogenesis.
Hu H; Liu Y; Jiang T
Tumour Biol; 2015 Mar; 36(3):1423-8. PubMed ID: 25750036
[TBL] [Abstract][Full Text] [Related]
2. Receptor tyrosine kinase mutations in developmental syndromes and cancer: two sides of the same coin.
McDonell LM; Kernohan KD; Boycott KM; Sawyer SL
Hum Mol Genet; 2015 Oct; 24(R1):R60-6. PubMed ID: 26152202
[TBL] [Abstract][Full Text] [Related]
3. Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics.
Li E; Hristova K
Cell Adh Migr; 2010; 4(2):249-54. PubMed ID: 20168077
[TBL] [Abstract][Full Text] [Related]
4. Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies.
Correll PH; Paulson RF; Wei X
Gene; 2006 Jun; 374():26-38. PubMed ID: 16524673
[TBL] [Abstract][Full Text] [Related]
5. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.
Li E; Hristova K
Biochemistry; 2006 May; 45(20):6241-51. PubMed ID: 16700535
[TBL] [Abstract][Full Text] [Related]
6. Receptor tyrosine kinases: from biology to pathology.
Choura M; Rebaï A
J Recept Signal Transduct Res; 2011 Dec; 31(6):387-94. PubMed ID: 22040163
[TBL] [Abstract][Full Text] [Related]
7. SHP2 acts both upstream and downstream of multiple receptor tyrosine kinases to promote basal-like and triple-negative breast cancer.
Matalkah F; Martin E; Zhao H; Agazie YM
Breast Cancer Res; 2016 Jan; 18(1):2. PubMed ID: 26728598
[TBL] [Abstract][Full Text] [Related]
8. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases.
Ostman A; Böhmer FD
Trends Cell Biol; 2001 Jun; 11(6):258-66. PubMed ID: 11356362
[TBL] [Abstract][Full Text] [Related]
9. Imaging strategies for receptor tyrosine kinase dimers in living cells.
Zhang X; Yin J; Pan W; Li Y; Li N; Tang B
Anal Bioanal Chem; 2023 Jan; 415(1):67-82. PubMed ID: 36190534
[TBL] [Abstract][Full Text] [Related]
10. Autoinhibitory mechanisms in receptor tyrosine kinases.
Hubbard SR
Front Biosci; 2002 Feb; 7():d330-40. PubMed ID: 11815286
[TBL] [Abstract][Full Text] [Related]
11. High-throughput selection of transmembrane sequences that enhance receptor tyrosine kinase activation.
He L; Hoffmann AR; Serrano C; Hristova K; Wimley WC
J Mol Biol; 2011 Sep; 412(1):43-54. PubMed ID: 21767549
[TBL] [Abstract][Full Text] [Related]
12. TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system.
Pierce AM; Keating AK
Brain Res; 2014 Jan; 1542():206-20. PubMed ID: 24184575
[TBL] [Abstract][Full Text] [Related]
13. Deceiving appearances: signaling by "dead" and "fractured" receptor protein-tyrosine kinases.
Kroiher M; Miller MA; Steele RE
Bioessays; 2001 Jan; 23(1):69-76. PubMed ID: 11135311
[TBL] [Abstract][Full Text] [Related]
14. Ligand bias in receptor tyrosine kinase signaling.
Karl K; Paul MD; Pasquale EB; Hristova K
J Biol Chem; 2020 Dec; 295(52):18494-18507. PubMed ID: 33122191
[TBL] [Abstract][Full Text] [Related]
15. Receptor tyrosine kinases and their activation in melanoma.
Easty DJ; Gray SG; O'Byrne KJ; O'Donnell D; Bennett DC
Pigment Cell Melanoma Res; 2011 Jun; 24(3):446-61. PubMed ID: 21320293
[TBL] [Abstract][Full Text] [Related]
16. Receptor tyrosine kinase transmembrane domain interactions: potential target for "interceptor" therapy.
Najumudeen AK
Sci Signal; 2010 Sep; 3(138):jc6. PubMed ID: 20823401
[TBL] [Abstract][Full Text] [Related]
17. Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.
Abou-Fayçal C; Hatat AS; Gazzeri S; Eymin B
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208660
[TBL] [Abstract][Full Text] [Related]
18. Mislocalisation of Activated Receptor Tyrosine Kinases - Challenges for Cancer Therapy.
Schmidt-Arras D; Böhmer FD
Trends Mol Med; 2020 Sep; 26(9):833-847. PubMed ID: 32593582
[TBL] [Abstract][Full Text] [Related]
19. Receptor tyrosine kinases: legacy of the first two decades.
Schlessinger J
Cold Spring Harb Perspect Biol; 2014 Mar; 6(3):. PubMed ID: 24591517
[TBL] [Abstract][Full Text] [Related]
20. Cell lines expressing recombinant transmembrane domain-activated receptor kinases as tools for drug discovery.
Weber H; Müller D; Müller M; Ortiz A; Birkle M; Umber S; Ketterer C; Siedentopf O; Feger D; Totzke F; Kubbutat M; Schaechtele C; Ballmer-Hofer K; Ehlert JE; Graeser R
J Biomol Screen; 2014 Dec; 19(10):1350-61. PubMed ID: 25260782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
